GROWTH OPPORTUNITIES IN DIGITAL, MICROBIOME-BASED, AND PREVENTIVE HEALTHCARE TECHNOLOGIES

GROWTH OPPORTUNITIES IN DIGITAL, MICROBIOME-BASED, AND PREVENTIVE HEALTHCARE TECHNOLOGIES

RELEASE DATE
14-Aug-2020
REGION
Global
Research Code: D759-00-17-00-00
SKU: HC03324-GL-TA_24639

$950.00

Special Price $807.50 save 15 %

In stock
SKU
HC03324-GL-TA_24639

$950.00

$807.50 save 15 %

DownloadLink

Pay by invoice

ENQUIRE NOW

Description

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides insights across recent innovations in digital health, microbiome, and flu vaccines technologies. The TOE also provides insights across latest advancements for chronic pain management and COVID-19 testing.

The Life Science, Health & Wellness TOE will feature disruptive technology advances in the global life sciences industry. The technologies and innovations profiled will encompass developments across genetic engineering, drug discovery and development, biomarkers, tissue engineering, synthetic biology, microbiome, disease management, as well as health and wellness among several other platforms.

The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare.

Keywords: Microbiome, digital health, vaccine AI, Molomics, drug repurposing, Repurpose.AI, proteome, CyclicaRx, flu vaccine, Biondvax, Flugen, Imutex, Seqirus, IQUR, Osivax, Vivaldi Biosciences, Emergex, Adagio, Iggenix, Duke-nus, Biorelate, Diagnosis, genomic testing, precision medicine, Pieriandx, data science, Blackthorn, autism, Sangamo, gut microbiome, Seres, gene therapy, HIV, F2G, Kineta, DNA Script, wound healing, Reapplix, enzyme, Novozymes, COVID-19

Table of Contents

INNOVATIONS IN LIFE SCIENCES, HEALTH & WELLNESS

  • MOLOMICS, BARCELONA, SPAIN
  • GROWTH OPPORTUNITIES
  • REPURPOSE.AI, US
  • GROWTH OPPORTUNITIES
  • CYCLICA RX, CANADA
  • GROWTH OPPORTUNITIES
  • BIONDVAX, ISRAEL
  • GROWTH OPPORTUNITIES
  • FLUGEN INC., US
  • GROWTH OPPORTUNITIES
  • IMUTEX, UK
  • GROWTH OPPORTUNITIES
  • BLUE WATER VACCINES INC., US
  • GROWTH OPPORTUNITIES
  • SEQIRUS LTD., UK
  • GROWTH OPPORTUNITIES
  • IQUR LIMITED, UK
  • GROWTH OPPORTUNITIES
  • OSIVAX, FRANCE
  • GROWTH OPPORTUNITIES
  • VIVALDI BIOSCIENCES, US
  • GROWTH OPPORTUNITIES
  • EMERGEX VACCINES HOLDING LTD., UK
  • GROWTH OPPORTUNITIES
  • ADAGIO THERAPEUTICS, US
  • GROWTH OPPORTUNITIES
  • IGGENIX, US
  • GROWTH OPPORTUNITIES
  • DUKE-NUS MEDICAL SCHOOL, SINGAPORE
  • GROWTH OPPORTUNITIES
  • BIORELATE, UK
  • GROWTH OPPORTUNITIES
  • PIERIANDX, US
  • GROWTH OPPORTUNITIES
  • BLACKTHORN THERaPEUTICS, US
  • GROWTH OPPORTUNITIES
  • SANGAMO THERAPEUTICS INC., US
  • GROWTH OPPORTUNITIES
  • SERES THERAPEUTICS INC., US
  • GROWTH OPPORTUNITIES
  • AMERICAN GENE TECHNOLOGIES INC., US
  • GROWTH OPPORTUNITIES
  • F2G, UK
  • GROWTH OPPORTUNITIES
  • KINETA, US
  • GROWTH OPPORTUNITIES
  • DNA SCRIPT, FRANCE
  • GROWTH OPPORTUNITIES
  • REAPPLIX A/S, DENMARK
  • GROWTH OPPORTUNITIES
  • NOVOZYMES, DENMARK
  • GROWTH OPPORTUNITIES

KEY CONTACTS

  • KEY CONTACTS
  • KEY CONTACTS
  • KEY CONTACTS
  • KEY CONTACTS
  • KEY CONTACTS
  • KEY CONTACTS
  • KEY CONTACTS
  • LEGAL DISCLAIMER
Related Research
This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides insights across recent innovations in digital health, microbiome, and flu vaccines technologies. The TOE also provides insights across latest advancements for chronic pain management and COVID-19 testing. The Life Science, Health & Wellness TOE will feature disruptive technology advances in the global life sciences industry. The technologies and innovations profiled will encompass developments across genetic engineering, drug discovery and development, biomarkers, tissue engineering, synthetic biology, microbiome, disease management, as well as health and wellness among several other platforms. The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare. Keywords: Microbiome, digital health, vaccine AI, Molomics, drug repurposing, Repurpose.AI, proteome, CyclicaRx, flu vaccine, Biondvax, Flugen, Imutex, Seqirus, IQUR, Osivax, Vivaldi Biosciences, Emergex, Adagio, Iggenix, Duke-nus, Biorelate, Diagnosis, genomic testing, precision medicine, Pieriandx, data science, Blackthorn, autism, Sangamo, gut microbiome, Seres, gene therapy, HIV, F2G, Kineta, DNA Script, wound healing, Reapplix, enzyme, Novozymes, COVID-19
More Information
No Index No
Podcast No
Industries Healthcare
WIP Number D759-00-17-00-00
Is Prebook No
Ti Codes D759